Scarica l'app Stockscreener
1.845
1.10%
0.025
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IOVA Giù?
Forum
Previsione
Frazionamento azionario
Iovance Biotherapeutics Inc Borsa (IOVA) Ultime notizie
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - Longview News-Journal
IOVA LAWSUIT NOTICE: Lose Money on Iovance Biotherapeutics, Inc.? BFA Law Alerts Investors that the Class Action Could Allow Investors to Recover Losses (NASDAQ:IOVA) - TradingView
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER - GlobeNewswire
Iovance Biotherapeutics’ Lifileucel Produces Durable Responses in 5-Year Analysis of Advanced Melanoma Data - CGTLive®
IOVA Investors Have the Opportunity to Lead the Iovance Biotherapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - StreetInsider
Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. (IOVA) InvestorsLead Plaintiff Deadline on July 14, 2025 - ACCESS Newswire
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit - Morningstar
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance Health, and Iovance and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
IOVA Stock News: Stockholders with Significant Losses Should Contact Shareholder Rights Law Firm Robbins LLP for Information About the Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - PR Newswire
IOVA STOCK: Suffer Losses on Iovance Biotherapeutics, Inc.? - GlobeNewswire
Iovance’s (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit– Hagens Berman - GlobeNewswire
July 14, 2025 Deadline Approaching: Join Class Action Against Iovance Biotherapeutics, Inc. (IOVA)Contact Levi & Korsinsky - ACCESS Newswire
Scott+Scott Attorneys at Law LLP Continues to Remind - GlobeNewswire
IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsELV - PR Newswire
Iovance Biotherapeutics (IOVA) Reports Promising Five-Year Results for Amtagvi Therapy | IOVA Stock News - GuruFocus
Iovance Biotherapeutics Reports Five-Year Results of Amtagvi Treatment Showing Sustained Responses and Survival in Advanced Melanoma Patients - Nasdaq
The Journal of Clinical Oncology Publishes Five-year - GlobeNewswire
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
IOVA STOCK: Suffer Losses on Iovance Biotherapeutics, Inc.? BFA Law Notifies Investors of Imminent July 14 Securities Class Action Deadline (NASDAQ:IOVA) - TradingView
Securities Class Action Lawsuit Filed Against Iovance Biotherapeutics, Inc. (IOVA)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Iovance - GlobeNewswire
ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVA - TradingView
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc.IOVA - PR Newswire
Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Contact Levi & Korsinsky to Join Class Action Before July 14, 2025 - ACCESS Newswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - StreetInsider
IOVA LAWSUIT ALERT: Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. InvestorsLead Plaintiff Deadline July 14, 2025 - ACCESS Newswire
Investors in Iovance Biotherapeutics, Inc. (IOVA): Protect Your RightsContact Levi & Korsinsky Before July 14, 2025 - ACCESS Newswire
Class Action Filed Against Iovance Biotherapeutics, Inc. (IOVA)July 14, 2025 Deadline to JoinContact Levi & Korsinsky - Eastern Progress
Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Urged to Join Class Action Before July 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
IOVA DEADLINE REMINDER: Iovance Biotherapeutics, Inc. Investors May Be Able to Recover LossesContact BFA Law by July 14 Class Action Deadline - ACCESS Newswire
Robbins LLP Reminds IOVA Stockholders That a Class Action Lawsuit was Filed Against Iovance ... - Eagle-Tribune
Robbins LLP Reminds IOVA Stockholders That a Class Action - GlobeNewswire
Robbins LLP Reminds IOVA Stockholders That a Class Action Lawsuit was Filed Against Iovance Biotherapeutics, Inc. Alleging the Company Misled Investors Regarding its Business Prospects - TradingView
Deadline Alert: Iovance Biotherapeutics, Inc. (IOVA) - GlobeNewswire
Deadline Alert: Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire
Where are the Opportunities in (IOVA) - news.stocktradersdaily.com
IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Investors in Iovance Biotherapeutics, Inc. Should Contact - GlobeNewswire
Investors in Iovance Biotherapeutics, Inc. Should Contact The Gross Law Firm Before July 14, 2025 to Discuss Your Rights – IOVA - TradingView
Scott+Scott Attorneys at Law LLP Continues to Remind Investors an Action Has Been Filed Against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) - TradingView
Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Iovance Biotherapeutics, Inc. (IOVA) Investors of July 14, 2025 Deadline - ACCESS Newswire
IOVA REMINDER: BFA Law Reminds Iovance Biotherapeutics, Inc. Investors of the Imminent July 14 Deadline in Securities Fraud Class Action (NASDAQ:IOVA) - TradingView
IOVA LAWSUIT ALERT: The Gross Law Firm Notifies Iovance Biotherapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - marketscreener.com
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER - GlobeNewswire
Lawsuit filed for Investors who lost money with shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) - openPR.com
IOVA Investors Have the Opportunity to Lead the Iovance Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure ... - Eagle-Tribune
ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVA - TradingView
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesIOVA - FinancialContent
D. E. Shaw & Co. Inc. Reduces Holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World
Bank of America Corp DE Has $5.49 Million Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World
Class Action Lawsuit Filed Against Iovance Biotherapeutics, Inc. (IOVA)Recover LossesContact Levi & Korsinsky Before July 14, 2025 - ACCESS Newswire
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK ... - Bluefield Daily Telegraph
IOVA Stock New: Contact Robbins LLP for Information About the Securities Fraud Class Action Against Iovance Biotherapeutics, Inc. and to Learn How to Be Lead Plaintiff for the Class - The Malaysian Reserve
Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Join Class Action Before July 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Morningstar
Iovance Biotherapeutics (IOVA) Faces Investor Lawsuit Over - GlobeNewswire
Iovance Biotherapeutics (IOVA) Faces Investor Lawsuit Over Growth Projections Following Stock Plunge – Hagens Berman - TradingView
0.87%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):